Wedbush Securities Has Lowered Bank New York Mellon (BK) Stake; Mylan N.V. (MYL) Covered By 14 Bullish Analysts Last Week

February 18, 2018 - By Marie Mckinney

Among 22 analysts covering Mylan Inc. (NASDAQ:MYL), 14 have Buy rating, 0 Sell and 8 Hold. Therefore 64% are positive. Mylan Inc. had 66 analyst reports since July 27, 2015 according to SRatingsIntel. Deutsche Bank maintained Mylan N.V. (NASDAQ:MYL) on Tuesday, July 28 with “Buy” rating. The company was reinitiated on Thursday, December 3 by Morgan Stanley. The firm has “Buy” rating given on Wednesday, August 16 by Citigroup. The firm has “Hold” rating given on Thursday, December 21 by Cantor Fitzgerald. The rating was maintained by RBC Capital Markets with “Hold” on Monday, June 12. On Monday, July 27 the stock rating was downgraded by Cowen & Co to “Market Perform”. Deutsche Bank maintained the shares of MYL in report on Friday, August 7 with “Buy” rating. Cowen & Co maintained the shares of MYL in report on Wednesday, October 4 with “Hold” rating. The firm has “Buy” rating by Citigroup given on Friday, November 13. The company was maintained on Friday, November 18 by Mizuho. See Mylan N.V. (NASDAQ:MYL) latest ratings:

16/02/2018 Broker: J.P. Morgan Rating: Buy New Target: $53.0
06/02/2018 Broker: BMO Capital Markets Rating: Buy New Target: $50.0 Maintain
25/01/2018 Broker: Susquehanna Rating: Buy New Target: $55.0 Maintain
24/01/2018 Broker: Deutsche Bank Rating: Buy New Target: $50.0
18/01/2018 Broker: Mizuho Rating: Buy Maintain
18/01/2018 Broker: Wells Fargo Rating: Hold New Target: $43.0 Maintain
11/01/2018 Broker: Goldman Sachs Rating: Buy New Target: $52.0 Upgrade
04/01/2018 Broker: Citigroup Rating: Buy New Target: $58.0 Maintain
03/01/2018 Broker: Leerink Swann Rating: Market Perform New Target: $44 Initiates Coverage On
21/12/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $41.0 Maintain

Wedbush Securities Inc decreased Bank New York Mellon (BK) stake by 22.64% reported in 2017Q3 SEC filing. Wedbush Securities Inc sold 5,771 shares as Bank New York Mellon (BK)’s stock declined 1.27%. The Wedbush Securities Inc holds 19,724 shares with $1.05M value, down from 25,495 last quarter. Bank New York Mellon now has $57.01 billion valuation. The stock increased 0.16% or $0.09 during the last trading session, reaching $56.25. About 3.38M shares traded. The Bank of New York Mellon Corporation (NYSE:BK) has risen 13.98% since February 18, 2017 and is uptrending. It has underperformed by 2.72% the S&P500.

Wedbush Securities Inc increased Tractor Supply Company (NASDAQ:TSCO) stake by 7,359 shares to 23,213 valued at $1.47M in 2017Q3. It also upped Teva Pharmaceutical Inds (NYSE:TEVA) stake by 24,828 shares and now owns 96,975 shares. Allegion Public Ltd (NYSE:ALLE) was raised too.

Among 25 analysts covering The Bank Of New York Mellon Corporation (NYSE:BK), 12 have Buy rating, 3 Sell and 10 Hold. Therefore 48% are positive. The Bank Of New York Mellon Corporation had 74 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Hold” on Friday, October 6. Deutsche Bank maintained the shares of BK in report on Tuesday, January 26 with “Buy” rating. The stock of The Bank of New York Mellon Corporation (NYSE:BK) earned “Mkt Perform” rating by Keefe Bruyette & Woods on Friday, January 20. The firm has “Neutral” rating by Credit Suisse given on Monday, April 24. The company was downgraded on Monday, November 21 by Buckingham Research. The firm has “Buy” rating given on Friday, September 9 by Deutsche Bank. Deutsche Bank maintained The Bank of New York Mellon Corporation (NYSE:BK) rating on Monday, July 18. Deutsche Bank has “Buy” rating and $46 target. The firm has “Hold” rating by Jefferies given on Friday, September 15. The stock of The Bank of New York Mellon Corporation (NYSE:BK) has “Hold” rating given on Wednesday, April 5 by RBC Capital Markets. The company was maintained on Friday, May 27 by Deutsche Bank.

Investors sentiment increased to 1.01 in Q3 2017. Its up 0.12, from 0.89 in 2017Q2. It increased, as 34 investors sold BK shares while 306 reduced holdings. 90 funds opened positions while 254 raised stakes. 832.75 million shares or 0.16% more from 831.44 million shares in 2017Q2 were reported. Bbva Compass Commercial Bank Inc holds 53,161 shares or 0.18% of its portfolio. Lombard Odier Asset Management (Switzerland) owns 5,119 shares or 0.03% of their US portfolio. Pinebridge Limited Partnership holds 544,410 shares or 0.69% of its portfolio. 24,758 were reported by Magnetar Financial Limited. Parsons Capital Management Ri holds 0.3% or 47,702 shares in its portfolio. Hall Laurie J Trustee has invested 0.16% in The Bank of New York Mellon Corporation (NYSE:BK). Moreover, Kcm Inv Advsr Limited Liability Com has 0.02% invested in The Bank of New York Mellon Corporation (NYSE:BK). First Interstate State Bank has invested 0.03% of its portfolio in The Bank of New York Mellon Corporation (NYSE:BK). Oregon Pub Employees Retirement Fund accumulated 111,793 shares. The Ohio-based Cleararc Capital Inc has invested 0.21% in The Bank of New York Mellon Corporation (NYSE:BK). Reliance Tru Of Delaware owns 0.22% invested in The Bank of New York Mellon Corporation (NYSE:BK) for 27,185 shares. Com Of Vermont holds 0.15% in The Bank of New York Mellon Corporation (NYSE:BK) or 28,885 shares. Hancock Hldgs has invested 0.11% in The Bank of New York Mellon Corporation (NYSE:BK). Moreover, Contravisory Invest Mgmt has 0% invested in The Bank of New York Mellon Corporation (NYSE:BK) for 61 shares. Eqis Mgmt invested 0.05% of its portfolio in The Bank of New York Mellon Corporation (NYSE:BK).

The stock increased 1.18% or $0.49 during the last trading session, reaching $42.14. About 3.42 million shares traded. Mylan N.V. (NASDAQ:MYL) has declined 7.73% since February 18, 2017 and is downtrending. It has underperformed by 24.43% the S&P500.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide. The company has market cap of $22.61 billion. The firm operates through three divisions: North America, Europe, and Rest of World. It has a 26.06 P/E ratio. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Investors sentiment decreased to 0.33 in 2017 Q3. Its down 1.00, from 1.33 in 2017Q2. It is negative, as 3 investors sold Mylan N.V. shares while 0 reduced holdings. 1 funds opened positions while 0 raised stakes. 155,019 shares or 7.99% less from 168,486 shares in 2017Q2 were reported. Vantage Investment Advsrs Lc has 712 shares for 0.01% of their portfolio. Gulf Financial Bank (Uk) Ltd accumulated 139,930 shares or 0.06% of the stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: